nature-plants

Nature Plants (nature-plants)

Journal positioning

Nature Plants is the Nature Portfolio journal devoted to plant science in its full

breadth — from molecular and cell biology through development, physiology, genetics,

and evolution to ecology and crop science — including the plant-associated microbes and

the agricultural and societal contexts in which plants matter. Its defining expectation

is a significant advance with broad significance: a finding that changes how a wide

plant-science readership thinks about a problem, not a clean but incremental result that

extends one specialist literature. A technically sound, narrowly framed specialist paper

with no broad significance is a poor fit, however careful the work. This skill is a **fit

/ venue-selection / re-framing** tool. It does not replace the journal's current author

guidelines. Before submitting, re-check the live Nature Plants submission guidance.

When to trigger

• The author names Nature Plants and wants a fit/framing check for a plant-science paper.
• A specialist molecular, physiological, or ecological plant result must be re-framed into

a broad-significance, Nature-style narrative for a wide plant audience.

• The author is choosing between Nature Plants, a Nature Portfolio sibling, and a strong

specialist plant journal such as the-plant-cell or new-phytologist.

• The author needs Nature Plants' desk-reject heuristics and a credible alternative route.

Scope & topic fit

• Molecular and cellular plant biology — signaling, gene regulation, cell architecture —

when the mechanism reframes a broadly held understanding.

• Plant development, physiology, and stress responses with conceptual reach beyond one

pathway or species.

• Plant genetics, genomics, and evolution, including domestication and trait architecture

with significance across taxa or systems.

• Plant ecology, plant–microbe and plant–environment interactions framed for cross-field

relevance.

• Crop science and agricultural plant biology when the finding has implications wider than

a single cultivar or trial.

• Methods and resources that open new questions for a broad plant-science community.

Method & evidence bar

• The central claim must carry broad plant-science significance, supported by evidence

matched to the method (genetic, molecular, physiological, ecological, or computational).

• Mechanistic claims require convergent lines of evidence — genetics plus biochemistry plus

cell biology where appropriate — not a single correlative assay.

• Genotype/phenotype and field/ecology claims need adequate replication, controls, and

appropriate statistics; species and germplasm provenance must be documented.

• Genomic, transcriptomic, and structural data must follow community deposition standards;

'-omics' claims need validation beyond list-generation.

• Data and code underlying the central result are expected per Nature reporting and

data-availability policy, with a completed reporting summary.

Structure & house style

• Nature Portfolio format: a significance-forward abstract and an introduction that frames

the broad problem and gap; re-check current article types (Article, Letter, Resource,

Perspective, etc.) on the live guide.

• Main display items must carry the broad-significance argument; specialist controls and

extended datasets move to supplementary information.

• Methods are detailed and reproducible; the reporting summary, statistics reporting, and

data/code statements are required per Nature policy.

• Framing should be legible to plant scientists outside the immediate subfield, not only to

specialists in the exact system.

Official-submission checklist

• Before giving submission-ready advice, read ../../resources/source-basis.md and

../../resources/official-source-map.md; start from the Nature Portfolio anchors, then

cite the current Nature Plants page you checked.

• Search the live site for "Nature Plants submission guidelines" and follow the current

version.

• Re-check article types, abstract/format expectations, the reporting summary, and the

data/code-availability policy.

• Confirm sequence/structure/germplasm deposition requirements and accession-number

reporting where applicable.

• Re-check competing-interests, funding, author-contribution, and AI-use disclosure, and

open-access terms.

• If the live official instructions conflict with this skill, the official instructions

win.

Pre-submission self-check

• [ ] The advance has broad plant-science significance, not just a clean specialist increment.
• [ ] The story is framed for plant scientists outside the immediate subfield, with detail in SI.
• [ ] Mechanistic claims rest on convergent evidence, not a single correlative assay.
• [ ] Replication, controls, statistics, and germplasm/species provenance are documented.
• [ ] '-omics' and sequence/structure data are deposited and validated beyond list-generation.
• [ ] Data/code availability and the Nature reporting summary are addressed.

Common desk-reject triggers

• A technically sound but incremental specialist result with no broad significance.
• Mechanism asserted from a single correlative experiment without genetic or biochemical support.
• Single-condition, single-genotype, or unreplicated phenotyping presented as general.
• '-omics' descriptive catalogues with no functional validation or conceptual advance.
• Framing pitched only to one subfield rather than the broad plant-science readership.

Re-routing decision

• Deep molecular/cellular mechanism, specialist depth → the-plant-cell or the-plant-journal.
• Ecology, physiology, environmental interactions breadth → new-phytologist.
• Field-scale agronomy and yield → field-crops-research.
• Food-systems significance dominant → nature-food.
• Broad cross-discipline conceptual advance → nature-ecology-and-evolution or nature-communications.

Output format

[Fit] High / Medium / Low (one-line reason)
[Target] Nature Plants
[Topic tags] <2–3 closest plant-science topics>
[Broad significance] <why it matters across plant science, not one subfield>
[Method/evidence] <does convergent evidence + reproducibility clear Nature Plants' bar?>
[Top risk] <the single most likely reason for rejection>
[Official items to re-check] <article type / reporting summary / data + accession policy / disclosures>
[Re-route suggestion] <if not a fit, a better-matched venue>